Xcout Intel
BBOT
BridgeBio Oncology Therapeutics (BBOT) is a biotechnology company focused on oncology therapeutics under its 'Best-in-RAS' initiative. The company maintains its corporate headquarters in South San Francisco, California.
Subscribe to see BBOT’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
BBOT at a glance
BBOT is a hospitality technology company headquartered in United States, founded in 2016. It has raised at least $19M across the 2 funding rounds on record. Its most recent funding round, Series A, raised $15M in July 2021. Xcout tracks 21 named people at BBOT, including Pedro J. Beltran (Chief Executive Officer).
BBOT leadership
- Pedro J. BeltranChief Executive Officer
- Idan Elmelech, MA, MBAChief Operating Officer
- Yong (Ben) BenChief Medical and Development Officer
- Jake BauerChairman
- Neil KumarExecutive Chairman
- Frank McCormickCofounder, Non-Executive Director
15 more named people on record for BBOT, with roles, board committees and tenure — see the full roster →
BBOT funding rounds
At least $19M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $15M | 7 named | |
| Seed | $4M | 12 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Get BBOT's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on BBOT in Xcout Intel
- 21 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access